Evidence map›Paper›PMID 38184646›Full record

ArticleGenome medicine2024

Combining a prioritization strategy and functional studies nominates 5'UTR variants underlying inherited retinal disease.

Alfredo Dueñas Rey, Marta Del Pozo Valero, Manon Bouckaert, Katherine A Wood, Filip Van den Broeck, Malena Daich Varela, Huw B Thomas, Mattias Van Heetvelde, Marieke De Bruyne, Stijn Van de Sompele and 15 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The role of untranslated region variants in Mendelian disease: a review.European journal of human genetics : EJHG · 2025
    Review
  7. Non-coding single-nucleotide and structural variants affecting the EYS putative promoter cause autosomal recessive retinitis pigmentosa.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 5 countries.

Alfredo Dueñas ReyCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Marta Del Pozo Valero *Center for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Manon Bouckaert *Center for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Katherine A WoodDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, UK.
Filip Van den BroeckDepartment of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
Malena Daich VarelaUCL Institute of Ophthalmology, University College London, London, UK.
Huw B ThomasDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, UK.
Mattias Van HeetveldeCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Marieke De BruyneCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Stijn Van de SompeleCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Miriam BauwensCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Hanne LenaertsCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Quinten MahieuCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Dragana JosifovaClinical Genetics Department, Guy's Hospital, London, UK.
Genomics England Research Consortium
Carlo RivoltaDepartment of Ophthalmology, University of Basel, Basel, Switzerland.
Raymond T O'KeefeDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, UK.
Jamie EllingfordDivision of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, UK.
Andrew R WebsterUCL Institute of Ophthalmology, University College London, London, UK.
Gavin ArnoUCL Institute of Ophthalmology, University College London, London, UK.
Carmen AyusoDepartment of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Julie De ZaeytijdDepartment of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
Bart P LeroyCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Elfride De BaereCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium.
Frauke CoppietersCenter for Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium. frauke.coppieters@ugent.be.ORCID 0000-0001-7224-0992
Ghent University Hospital · BEUniversity of Manchester · GBMoorfields Eye Hospital · GBChildren's Hospital of Philadelphia · USGuy's Hospital · GBInstituto de Salud Carlos III · ESUniversity of Leicester · GB

Funding

Foundation Fighting Blindness TA-GT-0621-0810-UGENTWellcome Trust
6 · The paper itself

Abstract

background5' untranslated regions (5'UTRs) are essential modulators of protein translation. Predicting the impact of 5'UTR variants is challenging and rarely performed in routine diagnostics. Here, we present a combined approach of a comprehensive prioritization strategy and functional assays to evaluate 5'UTR variation in two large cohorts of patients with inherited retinal diseases (IRDs).

methodsWe performed an isoform-level re-analysis of retinal RNA-seq data to identify the protein-coding transcripts of 378 IRD genes with highest expression in retina. We evaluated the coverage of their 5'UTRs by different whole exome sequencing (WES) kits. The selected 5'UTRs were analyzed in whole genome sequencing (WGS) and WES data from IRD sub-cohorts from the 100,000 Genomes Project (n = 2397 WGS) and an in-house database (n = 1682 WES), respectively. Identified variants were annotated for 5'UTR-relevant features and classified into seven categories based on their predicted functional consequence. We developed a variant prioritization strategy by integrating population frequency, specific criteria for each category, and family and phenotypic data. A selection of candidate variants underwent functional validation using diverse approaches.

resultsIsoform-level re-quantification of retinal gene expression revealed 76 IRD genes with a non-canonical retina-enriched isoform, of which 20 display a fully distinct 5'UTR compared to that of their canonical isoform. Depending on the probe design, 3-20% of IRD genes have 5'UTRs fully captured by WES. After analyzing these regions in both cohorts, we prioritized 11 (likely) pathogenic variants in 10 genes (ARL3, MERTK, NDP, NMNAT1, NPHP4, PAX6, PRPF31, PRPF4, RDH12, RD3), of which 7 were novel. Functional analyses further supported the pathogenicity of three variants. Mis-splicing was demonstrated for the PRPF31:c.-9+1G>T variant. The MERTK:c.-125G>A variant, overlapping a transcriptional start site, was shown to significantly reduce both luciferase mRNA levels and activity. The RDH12:c.-123C>T variant was found in cis with the hypomorphic RDH12:c.701G>A (p.Arg234His) variant in 11 patients. This 5'UTR variant, predicted to introduce an upstream open reading frame, was shown to result in reduced RDH12 protein but unaltered mRNA levels.

conclusionsThis study demonstrates the importance of 5'UTR variants implicated in IRDs and provides a systematic approach for 5'UTR annotation and validation that is applicable to other inherited diseases.

Indexed as

Nicotinamide-Nucleotide AdenylyltransferaseRetinal Diseases5' Untranslated RegionsAlcohol Oxidoreductasesc-Mer Tyrosine KinaseHumansProtein IsoformsRetina5' Untranslated RegionsAlcohol Oxidoreductasesc-Mer Tyrosine KinaseNicotinamide-Nucleotide AdenylyltransferaseNMNAT1 protein, humanProtein IsoformsRDH12 protein, human5’untranslated region (5’UTR)Functional studiesInherited retinal disease (IRD)In silico prioritizationNon-coding variationUpstream open reading frame (uORF)Variant interpretationWhole exome sequencing (WES)Whole genome sequencing (WGS)

Identifiers

PMID38184646
PMCPMC10771650
OpenAlexW4390636923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.